Literature DB >> 9607864

Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7.

P Feng1, K A Lampel, H Karch, T S Whittam.   

Abstract

Escherichia coli O157:H7 is a foodborne pathogen distinguished from typical E. coli by the production of Shiga toxins (Stx) and the inability to ferment sorbitol (SOR) and to express beta-glucuronidase (GUD) activity. An allele-specific probe for the GUD gene (uidA) and multilocus enzyme electrophoresis were used to elucidate stages in the evolutionary emergence of E. coli O157: H7. A point mutation at +92 in uidA was found only in O157:H7 and its nonmotile relatives, including a SOR+ O157:H clone implicated in outbreaks of hemolytic-uremic syndrome in Germany. The results support a model in which O157:H7 evolved sequentially from an O55:H7 ancestor, first by acquiring the Stx2 gene and then by diverging into two branches; one became GUD- SOR- , resulting in the O157:H7 clone that spread worldwide, and the other lost motility, leading to the O157:H clone that is an increasing public health problem in Europe.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607864     DOI: 10.1086/517438

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  111 in total

Review 1.  Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  M S Donnenberg; T S Whittam
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Strains of Escherichia coli O157:H7 differ primarily by insertions or deletions, not single-nucleotide polymorphisms.

Authors:  Indira T Kudva; Peter S Evans; Nicole T Perna; Timothy J Barrett; Frederick M Ausubel; Frederick R Blattner; Stephen B Calderwood
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

3.  Ancestral divergence, genome diversification, and phylogeographic variation in subpopulations of sorbitol-negative, beta-glucuronidase-negative enterohemorrhagic Escherichia coli O157.

Authors:  J Kim; J Nietfeldt; J Ju; J Wise; N Fegan; P Desmarchelier; A K Benson
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

Review 4.  Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis.

Authors:  H Karch; M Bielaszewska
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Acquisition of the rfb-gnd cluster in evolution of Escherichia coli O55 and O157.

Authors:  P I Tarr; L M Schoening; Y L Yea; T R Ward; S Jelacic; T S Whittam
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

6.  An Escherichia coli reference collection group B2- and uropathogen-associated polymorphism in the rpoS-mutS region of the E. coli chromosome.

Authors:  D E Culham; J M Wood
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

7.  Diversity, frequency, and persistence of Escherichia coli O157 strains from range cattle environments.

Authors:  David G Renter; Jan M Sargeant; Richard D Oberst; Mansour Samadpour
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

8.  Evaluation of a real-time PCR kit for detecting Escherichia coli O157 in bovine fecal samples.

Authors:  James L Bono; James E Keen; Laura C Miller; James M Fox; Carol G Chitko-McKown; Michael P Heaton; William W Laegreid
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

9.  Genomic variability of O islands encoding tellurite resistance in enterohemorrhagic Escherichia coli O157:H7 isolates.

Authors:  Diane E Taylor; Michelle Rooker; Monika Keelan; Lai-King Ng; Irene Martin; Nicole T Perna; N T Valerie Burland; Fredrick R Blattner
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

Review 10.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.